This study shows that oral treatment of L.p R3 significantly inhibited the development of MC38 tumor in mice, moreover, the combinatorial treatment of L.p R3 with PD-1 could significantly promote immune therapy and extend lifespan of MC38 tumor-bearing mice. This evidence concerns the gene PDCD1 and neoplasm.